Experts say discontinuing General Motors' all-electric pickups would be more complicated than it was for the other automakers ...
Jason Beres COO of Infragistics spearheads the customer-driven, innovative features and functionality throughout all Infragistics' software, including testing, development, and user experience. Jason ...
Heidi Weng, Karoline Simpson-Larsen, Astrid Oyre Slind, and Kristin Austgulen Fosnaes, of Norway, celebrate on the podium ...
In an exclusive chat with Hannah Abraham, the Korean entertainment giant reveals it's pivoting from short-term content sales ...
The director behind the first all-Pakistani feature at the Berlin Film Festival speaks about tonal flips, the social weight marriage imposes and finding artistic kinship in a tenuous film industry ...
Grand juries in recent federal cases have declined to indict in matters that prosecutors appeared confident would proceed, ...
Alexander Zhou, a 9-year-old Chinese American fourth grader at New York City’s Special Music School at Kaufman Music Center, went viral after performing Moritz Moszkowski’s Etincelles, Op. The ...
Bizcommunity on MSN
Corporate hiring trends: Is your CV becoming obsolete?
For years, the CV has been the hiring world’s default currency. A neat, two-page summary of who you are, where you’ve been, and what you’ve done. But in 2026, the uncomfortable truth is this: the CV ...
Few people have actually used the pre-trial supervision program since it was launched two years ago. Now lawmakers are deciding if it's worth investing in.
Pablo Ormachea, VP of Data at Motus, builds enterprise AI and analytics systems designed to move quickly while standing up to regulatory and financial scrutiny. He leads fully remote, cross-functional ...
1don MSN
After unprecedented string of tragedies, Minnesota legislature will return Tuesday for 2026 session
Immigration enforcement, gun violence and fraud will take center stage at the capitol, which is still reeling from the murder ...
As the pharma patent cliff approaches, delve into which important drugs are about to lose exclusivity and how the industry is reacting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results